Mortality as a result of sepsis and septic shock is still high despite the use of anti-microbial agents. Intravenous Immunoglobulins (IVIgs) have been proposed as adjuvant therapy for sepsis even though their efficacy in this setting has long been debated. We describe the case of a patient with sepsis treated with IVIgs developing bradycardia. Bradycardia progressively improved with the IVIgs washout, and spontaneously resolved after two days from the end of the treatment. Further studies are needed to ascertain this possible link.
To cite this article
Sinus bradycardia in a patient with bacterial meningitis in therapy with IVIg: a case report
Infectious Diseases & Tropical Medicine 2019;
Submission date: 15 Jul 2019
Revised on: 05 Aug 2019
Accepted on: 29 Aug 2019
Published online: 06 Sep 2019
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.